USA - engelsk - NLM (National Library of Medicine)

vedco - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), mometasone furoate (unii: 04201gdn4r) (mometasone - unii:8hr4qj6dw8), clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - gentamicin 3 mg in 1 g - indications: gentamicin sulfate, usp; mometasone furoate anhydrous; and clotrimazole, usp, otic suspension is indicated for the treatment of otitis externa in dogs caused by susceptible strains of yeast (malassezia pachydermatis) and bacteria (pseudomonas spp. [including p . aeruginosa ], coagulase-positive staphylococci, enterococcus faecalis, proteus mirabilis, and beta-hemolytic streptococci). contraindications: if hypersensitivity to any of the components occurs, treatment should be discontinued and appropriate therapy instituted. concomitant use of drugs known to induce ototoxicity should be avoided.  do not use in dogs with known perforation of eardrums.

USA - engelsk - NLM (National Library of Medicine)

clipper distribution company llc - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), mometasone furoate (unii: 04201gdn4r) (mometasone - unii:8hr4qj6dw8), clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - gentamicin 3 mg in 1 g - indications: gentamicin sulfate, usp; mometasone furoate anhydrous; and clotrimazole, usp, otic suspension is indicated for the treatment of otitis externa in dogs caused by susceptible strains of yeast (malassezia pachydermatis) and bacteria (pseudomonas spp. [including p . aeruginosa ], coagulase-positive staphylococci, enterococcus faecalis, proteus mirabilis, and beta-hemolytic streptococci). contraindications: if hypersensitivity to any of the components occurs, treatment should be discontinued and appropriate therapy instituted. concomitant use of drugs known to induce ototoxicity should be avoided.  do not use in dogs with known perforation of eardrums.

USA - engelsk - NLM (National Library of Medicine)

vedco - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - gentamicin 3 mg in 1 ml - indications: gentamicin sulfate with betamethasone valerate otic solution is indicated for the treatment of acute and chronic canine otitis externa and canine and feline superficial infected lesions caused by bacteria sensitive to gentamicin. contraindications: if hypersensitivity of any of the components occurs, treatment with this product should be discontinued and appropriate therapy instituted. concomitant use of drugs known to induce ototoxicity should be avoided. this preparation should not be used in conditions where corticosteroids are contraindicated. do not administer parenteral corticosteroids during treatment with gentamicin sulfate with betamethasone valerate otic solution.

USA - engelsk - NLM (National Library of Medicine)

mwi - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - gentamicin 3 mg in 1 ml - indications: gentamicin sulfate with betamethasone valerate otic solution is indicated for the treatment of acute and chronic canine otitis externa and canine and feline superficial infected lesions caused by bacteria sensitive to gentamicin. contraindications: if hypersensitivity of any of the components occurs, treatment with this product should be discontinued and appropriate therapy instituted. concomitant use of drugs known to induce ototoxicity should be avoided. this preparation should not be used in conditions where corticosteroids are contraindicated. do not administer parenteral corticosteroids during treatment with gentamicin sulfate with betamethasone valerate otic solution.

USA - engelsk - NLM (National Library of Medicine)

clipper distributing company llc - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - gentamicin 3 mg in 1 ml - indications: gentamicin sulfate with betamethasone valerate otic solution is indicated for the treatment of acute and chronic canine otitis externa and canine and feline superficial infected lesions caused by bacteria sensitive to gentamicin. contraindications: if hypersensitivity of any of the components occurs, treatment with this product should be discontinued and appropriate therapy instituted. concomitant use of drugs known to induce ototoxicity should be avoided. this preparation should not be used in conditions where corticosteroids are contraindicated. do not administer parenteral corticosteroids during treatment with gentamicin sulfate with betamethasone valerate otic solution.

USA - engelsk - NLM (National Library of Medicine)

henry schein animal health - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - gentamicin 3 mg in 1 ml - indications: gentamicin sulfate with betamethasone valerate otic solution is indicated for the treatment of acute and chronic canine otitis externa and canine and feline superficial infected lesions caused by bacteria sensitive to gentamicin. contraindications: if hypersensitivity of any of the components occurs, treatment with this product should be discontinued and appropriate therapy instituted. concomitant use of drugs known to induce ototoxicity should be avoided. this preparation should not be used in conditions where corticosteroids are contraindicated. do not administer parenteral corticosteroids during treatment with gentamicin sulfate with betamethasone valerate otic solution.

USA - engelsk - NLM (National Library of Medicine)

fresenius kabi usa, llc - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg) - gentamicin 10 mg in 1 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of gentamicin injection, usp and other antibacterial drugs, gentamicin injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.  when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy.  in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. gentamicin injection is indicated in the treatment of serious infections caused by susceptible strains of the following microorganisms: pseudomonas aeruginosa, proteus species (indole-positive and indole-negative), escherichia coli, klebsiella-enterobacter-serratia species, citrobacter species, and staphylococcus species (coagulase-positive and coagulase-negative). clinical studies have shown gentamicin

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - gentamicin as gentamicin sulfate - parenteral liquid/solution/suspension - gentamicin as gentamicin sulfate antibiotic active 50.0 mg/ml - antibiotic & related - cat - not pregnant | dog - not pregnant | horse - not pregnant - bacterial infection | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

panpharma - gentamicine 160 mg sous forme de : gentamicine (sulfate de) - solution - 160 mg - pour 2 ml > gentamicine 160 mg sous forme de : gentamicine (sulfate de) - autres aminosides - classe pharmacothérapeutique : autres aminosides - code atc : j01gb03gentamicine panpharma 160 mg, solution injectable est indiqué chez l’adulte et chez l’enfant : en traitement curatif d’infections sévères dues à des espèces bactériennes identifiées ou suspectées, microbiologiquement sensibles à la gentamicine. dans ces conditions, gentamicine panpharma 160 mg, solution injectable peut être utilisé :o dans les maladies suivantes :§ les infections urinaires§ les infections lors de l’inflammation de la paroi intérieure du cœur§ les infections des membranes enveloppant le système nerveux central§ les infections des os et des articulations§ les listérioses (infections du corps entier dû à la présence de listeria monocytogenes dans le sang) en traitement préventif des infections post-opératoires et lors d’actes radiologiques et médecine interventionnelle, selon les recommandations de bon usage des antibiotiques.

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

panpharma - gentamicine 40 mg sous forme de : gentamicine (sulfate de) - solution - 40 mg - pour 2 ml > gentamicine 40 mg sous forme de : gentamicine (sulfate de) - autres aminosides - classe pharmacothérapeutique : autres aminosides - code atc : j01gb03gentamicine panpharma 40 mg, solution injectable est indiqué chez l’adulte et chez l’enfant : en traitement curatif d’infections sévères dues à des espèces bactériennes identifiées ou suspectées, microbiologiquement sensibles à la gentamicine. dans ces conditions, gentamicine panpharma 40 mg, solution injectable peut être utilisé :o dans les maladies suivantes :§ les infections urinaires§ les infections lors de l’inflammation de la paroi intérieure du cœur§ les infections des membranes enveloppant le système nerveux central§ les infections des os et des articulations§ les listérioses (infections du corps entier dû à la présence de listeria monocytogenes dans le sang) en traitement préventif des infections post-opératoires et lors d’actes radiologiques et médecine interventionnelle, selon les recommandations de bon usage des antibiotiques.